Literature DB >> 25275813

Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens From Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction.

Angela N Bartley1, Jessi Christ, Patrick L Fitzgibbons, Stanley R Hamilton, Sanjay Kakar, Manish A Shah, Laura H Tang, Megan L Troxell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25275813     DOI： 10.5858/arpa.2014-0395-CP

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  9 in total

Review 1.  Pathology of esophageal cancer and Barrett's esophagus.

Authors:  Shilpa Jain; Sadhna Dhingra
Journal:  Ann Cardiothorac Surg       Date:  2017-03

Review 2.  HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.

Authors:  Angela N Bartley; Mary Kay Washington; Christina B Ventura; Nofisat Ismaila; Carol Colasacco; Al B Benson; Alfredo Carrato; Margaret L Gulley; Dhanpat Jain; Sanjay Kakar; Helen J Mackay; Catherine Streutker; Laura Tang; Megan Troxell; Jaffer A Ajani
Journal:  Am J Clin Pathol       Date:  2016-11-14       Impact factor: 2.493

3.  Prognostic significance of performing universal HER2 testing in cases of advanced gastric cancer.

Authors:  Paula Jiménez-Fonseca; Alberto Carmona-Bayonas; Maria Luisa Sánchez Lorenzo; Javier Gallego Plazas; Ana Custodio; Raquel Hernández; Marcelo Garrido; Teresa García; Isabel Echavarría; Juana María Cano; Alberto Rodríguez Palomo; Monserrat Mangas; Ismael Macías Declara; Avinash Ramchandani; Laura Visa; Antonio Viudez; Elvira Buxó; Asunción Díaz-Serrano; Carlos López; Aitor Azkarate; Federico Longo; Eduardo Castañón; Rodrigo Sánchez Bayona; Paola Pimentel; Maria Luisa Limón; Paula Cerdá; Renata Álvarez Llosa; Raquel Serrano; Maria Pilar Felices Lobera; María Alsina; Alicia Hurtado Nuño; Carlos Gómez-Martin
Journal:  Gastric Cancer       Date:  2016-09-06       Impact factor: 7.370

4.  Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.

Authors:  Dara S Ross; Ahmet Zehir; Donavan T Cheng; Ryma Benayed; Khedoudja Nafa; Jaclyn F Hechtman; Yelena Y Janjigian; Britta Weigelt; Pedram Razavi; David M Hyman; José Baselga; Michael F Berger; Marc Ladanyi; Maria E Arcila
Journal:  J Mol Diagn       Date:  2016-12-25       Impact factor: 5.568

5.  Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.

Authors:  Daniel V T Catenacci; Wei-Li Liao; Lei Zhao; Emma Whitcomb; Les Henderson; Emily O'Day; Peng Xu; Sheeno Thyparambil; David Krizman; Kathleen Bengali; Jamar Uzzell; Marlene Darfler; Fabiola Cecchi; Adele Blackler; Yung-Jue Bang; John Hart; Shu-Yuan Xiao; Sang Mee Lee; Jon Burrows; Todd Hembrough
Journal:  Gastric Cancer       Date:  2015-11-18       Impact factor: 7.370

6.  Cancer diagnostics: The journey from histomorphology to molecular profiling.

Authors:  Atif A Ahmed; Malak Abedalthagafi
Journal:  Oncotarget       Date:  2016-09-06

7.  Objective, domain-specific HER2 measurement in uterine and ovarian serous carcinomas and its clinical significance.

Authors:  Daniel E Carvajal-Hausdorf; Kurt A Schalper; Yalai Bai; Jonathan Black; Alessandro D Santin; David L Rimm
Journal:  Gynecol Oncol       Date:  2017-02-11       Impact factor: 5.482

8.  Investigation of HER-2 Expression an Its Correlation with Clinicopathological Parameters and Overall Survival of Esophageal Squamous Cell Carcinoma Patients.

Authors:  Mitra Heidarpour; Mehran Taheri; Ali Akhavan; Parvin Goli; Amirhosein Kefayat
Journal:  Iran J Pathol       Date:  2020-07-16

9.  Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal Cancer.

Authors:  Soledad Iseas; Juan M Sendoya; Juan Robbio; Mariana Coraglio; Mirta Kujaruk; Vanesa Mikolaitis; Mariana Rizzolo; Ana Cabanne; Gonzalo Ruiz; Rubén Salanova; Ubaldo Gualdrini; Guillermo Méndez; Marina Antelo; Marcela Carballido; Cecilia Rotondaro; Julieta Viglino; Martín Eleta; Alejandro Di Sibio; Osvaldo L Podhajcer; Enrique Roca; Andrea S Llera; Mariano Golubicki; Martín Carlos Abba
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.